PT

Proteostasis Therapeutics

Acquired

Boston, United States · Founded 2006 · $82.0M raised

Employees
11–50
Founded
2006
Business Model
B2B
Total Funding
$82.0M
Last Round
$37.0M Convertible NoteSep 2015
Rounds
2
Acquisition Date
Dec 2020

About

Proteostasis Therapeutics was a clinical-stage biopharmaceutical company focused on discovering and developing small-molecule therapeutics to treat cystic fibrosis and other diseases caused by dysfunctional protein processing. Founded in 2006 and based in Boston, Massachusetts, the company traded on Nasdaq under the ticker PTI. After its CF drug candidates underperformed against Vertex's pipeline, Proteostasis merged with Yumanity Therapeutics in 2020.

Summary

Proteostasis Therapeutics is a Biotech company based in Boston, United States, founded in 2006. It has raised $82.0M in total across 2 rounds, most recently a $37.0M Convertible Note round in Sep 2015. Investors include New Enterprise Associates, Cormorant Asset Management and Rock Springs Capital.

Funding History

AcquisitionDec 2020

Sign up to see all 4 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Proteostasis Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/proteostasis-therapeutics"><img src="https://indexed.vc/api/badge/company/proteostasis-therapeutics" alt="Proteostasis Therapeutics on Indexed.vc" width="260" height="76" /></a>